Who is sponsoring NCT04120805?

NCT04120805 is sponsored by University of Chicago.

What condition does NCT04120805 study?

NCT04120805 studies Kidney Cancer.

What drugs are being tested in NCT04120805?

Interventions: Hemostatic Agent, No Hemostatic Agent.

What is the status of NCT04120805?

NCT04120805 is currently ACTIVE_NOT_RECRUITING.

Last reviewed 2025-05-30 · How we verify

Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy

NCT04120805 NA ACTIVE_NOT_RECRUITING

The purpose of this study is to evaluate the necessity of using hemostatic agents as a tool when performing robotic partial nephrectomy in the treatment of kidney cancer. This project asks whether patients who undergo robotic partial nephrectomy without the surgeon using hemostatic agents during the procedure will have the same, fewer, or more complications than when patients undergo this same surgery with the surgeon using hemostatic agents during the procedure.

Details

Lead sponsor	University of Chicago
Phase	NA
Status	ACTIVE_NOT_RECRUITING
Enrolment	178
Start date	Fri Jan 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Mar 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Kidney Cancer

Interventions

Hemostatic Agent
No Hemostatic Agent

Countries

United States